De novo CpG island methylation in human cancer cells
A major obstacle toward understanding how patterns of abnormal mammalian cytosine DNA methylation are established is the difficulty in quantitating the de novo methylation activities of DNA methyltransferases (DNMT) thought to catalyze these reactions. Here, we describe a novel method, using native...
Uloženo v:
| Vydáno v: | Cancer research (Chicago, Ill.) Ročník 66; číslo 2; s. 682 |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
15.01.2006
|
| Témata: | |
| ISSN: | 0008-5472 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | A major obstacle toward understanding how patterns of abnormal mammalian cytosine DNA methylation are established is the difficulty in quantitating the de novo methylation activities of DNA methyltransferases (DNMT) thought to catalyze these reactions. Here, we describe a novel method, using native human CpG island substrates from genes that frequently become hypermethylated in cancer, which generates robust activity for measuring de novo CpG methylation. We then survey colon cancer cells with genetically engineered deficiencies in different DNMTs and find that the major activity against these substrates in extracts of these cells is DNMT1, with minor contribution from DNMT 3b and none from DNMT3a, the only known bona fide de novo methyltransferases. The activity of DNMT1 against unmethylated CpG rich DNA was further tested by introducing CpG island substrates and DNMT1 into Drosophila melanogaster cells. The exogenous DNMT1 methylates the integrated mammalian CpG islands but not the Drosophila DNA. Additionally, in human cancer cells lacking DNMT1 and DNMT3b and having nearly absent genomic methylation, gene-specific de novo methylation can be initiated by reintroduction of DNMT1. Our studies provide a new assay for de novo activity of DNMTs and data suggesting a potential role for DNMT1 in the initiation of promoter CpG island hypermethylation in human cancer cells. |
|---|---|
| AbstractList | A major obstacle toward understanding how patterns of abnormal mammalian cytosine DNA methylation are established is the difficulty in quantitating the de novo methylation activities of DNA methyltransferases (DNMT) thought to catalyze these reactions. Here, we describe a novel method, using native human CpG island substrates from genes that frequently become hypermethylated in cancer, which generates robust activity for measuring de novo CpG methylation. We then survey colon cancer cells with genetically engineered deficiencies in different DNMTs and find that the major activity against these substrates in extracts of these cells is DNMT1, with minor contribution from DNMT 3b and none from DNMT3a, the only known bona fide de novo methyltransferases. The activity of DNMT1 against unmethylated CpG rich DNA was further tested by introducing CpG island substrates and DNMT1 into Drosophila melanogaster cells. The exogenous DNMT1 methylates the integrated mammalian CpG islands but not the Drosophila DNA. Additionally, in human cancer cells lacking DNMT1 and DNMT3b and having nearly absent genomic methylation, gene-specific de novo methylation can be initiated by reintroduction of DNMT1. Our studies provide a new assay for de novo activity of DNMTs and data suggesting a potential role for DNMT1 in the initiation of promoter CpG island hypermethylation in human cancer cells. A major obstacle toward understanding how patterns of abnormal mammalian cytosine DNA methylation are established is the difficulty in quantitating the de novo methylation activities of DNA methyltransferases (DNMT) thought to catalyze these reactions. Here, we describe a novel method, using native human CpG island substrates from genes that frequently become hypermethylated in cancer, which generates robust activity for measuring de novo CpG methylation. We then survey colon cancer cells with genetically engineered deficiencies in different DNMTs and find that the major activity against these substrates in extracts of these cells is DNMT1, with minor contribution from DNMT 3b and none from DNMT3a, the only known bona fide de novo methyltransferases. The activity of DNMT1 against unmethylated CpG rich DNA was further tested by introducing CpG island substrates and DNMT1 into Drosophila melanogaster cells. The exogenous DNMT1 methylates the integrated mammalian CpG islands but not the Drosophila DNA. Additionally, in human cancer cells lacking DNMT1 and DNMT3b and having nearly absent genomic methylation, gene-specific de novo methylation can be initiated by reintroduction of DNMT1. Our studies provide a new assay for de novo activity of DNMTs and data suggesting a potential role for DNMT1 in the initiation of promoter CpG island hypermethylation in human cancer cells.A major obstacle toward understanding how patterns of abnormal mammalian cytosine DNA methylation are established is the difficulty in quantitating the de novo methylation activities of DNA methyltransferases (DNMT) thought to catalyze these reactions. Here, we describe a novel method, using native human CpG island substrates from genes that frequently become hypermethylated in cancer, which generates robust activity for measuring de novo CpG methylation. We then survey colon cancer cells with genetically engineered deficiencies in different DNMTs and find that the major activity against these substrates in extracts of these cells is DNMT1, with minor contribution from DNMT 3b and none from DNMT3a, the only known bona fide de novo methyltransferases. The activity of DNMT1 against unmethylated CpG rich DNA was further tested by introducing CpG island substrates and DNMT1 into Drosophila melanogaster cells. The exogenous DNMT1 methylates the integrated mammalian CpG islands but not the Drosophila DNA. Additionally, in human cancer cells lacking DNMT1 and DNMT3b and having nearly absent genomic methylation, gene-specific de novo methylation can be initiated by reintroduction of DNMT1. Our studies provide a new assay for de novo activity of DNMTs and data suggesting a potential role for DNMT1 in the initiation of promoter CpG island hypermethylation in human cancer cells. |
| Author | Schuebel, Kornel E Ting, Angela H Rhee, Ina Suzuki, Hiromu Baylin, Stephen B Bachman, Kurtis E Yen, Ray-Whay Chiu Jair, Kam-Wing |
| Author_xml | – sequence: 1 givenname: Kam-Wing surname: Jair fullname: Jair, Kam-Wing organization: The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, 1650 Orleans Street, Baltimore, MD 21231, USA – sequence: 2 givenname: Kurtis E surname: Bachman fullname: Bachman, Kurtis E – sequence: 3 givenname: Hiromu surname: Suzuki fullname: Suzuki, Hiromu – sequence: 4 givenname: Angela H surname: Ting fullname: Ting, Angela H – sequence: 5 givenname: Ina surname: Rhee fullname: Rhee, Ina – sequence: 6 givenname: Ray-Whay Chiu surname: Yen fullname: Yen, Ray-Whay Chiu – sequence: 7 givenname: Stephen B surname: Baylin fullname: Baylin, Stephen B – sequence: 8 givenname: Kornel E surname: Schuebel fullname: Schuebel, Kornel E |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16423997$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9j8lOwzAYhH0oogs8Asgnbi624y3HKtCCVMEFzpGXP2pQ4oQ4QerbU0ThNJrRp9HMEs1iFwGhG0bXjElzTyk1RArN18XmhVBJWG7oDC3-8zlapvRxspJReYnmTAme5bleIPEAOHZfHS76Ha5TY2PALYyHY2PHuou4jvgwtTZib6OHAXtomnSFLirbJLg-6wq9bx_fiieyf909F5s98SJTI8nzKjjGvVJWSOFdAO6EZOCcERyyABnzFTCtjNZQMa60roSyygQFyjHHV-jut7cfus8J0li2dfpZYCN0Uyo1VUZQqU_g7RmcXAuh7Ie6tcOx_PvJvwGLlVTA |
| CitedBy_id | crossref_primary_10_1007_s00204_012_0983_3 crossref_primary_10_1371_journal_pone_0054114 crossref_primary_10_1158_1541_7786_MCR_09_0496 crossref_primary_10_3390_cells11071095 crossref_primary_10_1093_carcin_bgs006 crossref_primary_10_1186_1745_6150_8_14 crossref_primary_10_1002_em_21987 crossref_primary_10_1016_j_chest_2022_12_036 crossref_primary_10_1016_j_phrs_2019_104352 crossref_primary_10_1002_jcp_24141 crossref_primary_10_3389_fonc_2023_1010132 crossref_primary_10_1097_ACO_0b013e3283556211 crossref_primary_10_3390_ijms242015238 crossref_primary_10_1111_j_1365_2583_2011_01092_x crossref_primary_10_1016_j_envpol_2023_121931 crossref_primary_10_1074_jbc_M603140200 crossref_primary_10_1016_j_yexmp_2017_05_005 crossref_primary_10_1186_1476_4598_5_16 crossref_primary_10_1016_j_prp_2018_07_015 crossref_primary_10_1208_s12248_013_9493_3 crossref_primary_10_1038_modpathol_3800822 crossref_primary_10_3322_caac_20085 crossref_primary_10_1002_ijc_23494 crossref_primary_10_1007_s00204_014_1315_6 crossref_primary_10_1128_MCB_01516_07 crossref_primary_10_3390_ph3072022 crossref_primary_10_1371_journal_pgen_1001286 crossref_primary_10_1007_s11033_015_3931_5 crossref_primary_10_1016_j_ejphar_2021_174698 crossref_primary_10_2217_epi_09_45 crossref_primary_10_1002_path_4120 crossref_primary_10_1039_D3FO03831A crossref_primary_10_3390_cancers11060797 crossref_primary_10_1016_j_toxlet_2009_08_018 crossref_primary_10_1093_nar_gks031 crossref_primary_10_1371_journal_pone_0142034 crossref_primary_10_4161_epi_29676 crossref_primary_10_1016_j_bbamcr_2013_12_016 crossref_primary_10_1016_j_str_2008_01_004 crossref_primary_10_2217_epi_2016_0175 crossref_primary_10_1074_jbc_M110_155721 crossref_primary_10_1016_j_canlet_2008_03_022 crossref_primary_10_1128_MCB_01073_07 crossref_primary_10_1139_o06_090 crossref_primary_10_1186_s13148_018_0450_y crossref_primary_10_1517_14712598_2013_819337 crossref_primary_10_4161_15384101_2014_950886 crossref_primary_10_1111_j_1600_0463_2007_apm_776_xml_x crossref_primary_10_1186_s13148_015_0095_z crossref_primary_10_1038_s10038_019_0611_7 crossref_primary_10_3390_ijms19020478 crossref_primary_10_1101_gad_1464906 crossref_primary_10_1002_1873_3468_12331 crossref_primary_10_1101_gad_1470906 crossref_primary_10_3390_genes9120620 crossref_primary_10_1016_j_bbrc_2011_07_115 crossref_primary_10_1038_s41598_017_16357_7 crossref_primary_10_1016_j_envres_2013_10_006 crossref_primary_10_1007_s00784_016_1772_9 crossref_primary_10_1016_j_aspen_2022_101879 crossref_primary_10_1093_abbs_gmq015 crossref_primary_10_1158_0008_5472_CAN_06_1937 crossref_primary_10_1016_j_ccell_2019_03_003 crossref_primary_10_1080_15592294_2016_1253651 crossref_primary_10_1016_j_currproblcancer_2018_03_001 crossref_primary_10_1093_carcin_bgm303 crossref_primary_10_1089_cell_2009_0083 crossref_primary_10_1242_dev_032227 crossref_primary_10_1186_1479_5876_4_32 crossref_primary_10_1080_01635581_2014_951727 crossref_primary_10_1002_cne_23020 crossref_primary_10_1016_j_mambio_2019_07_007 crossref_primary_10_4161_cbt_27630 crossref_primary_10_1007_s40291_016_0244_x crossref_primary_10_3390_biom11101406 crossref_primary_10_1038_embor_2011_110 crossref_primary_10_3390_dna3030010 crossref_primary_10_1016_j_molimm_2012_06_010 crossref_primary_10_1038_ncomms11453 crossref_primary_10_1245_s10434_014_4277_2 crossref_primary_10_3892_ijo_2013_1931 crossref_primary_10_1083_jcb_202307026 crossref_primary_10_1074_jbc_M601155200 crossref_primary_10_3390_cells8080912 crossref_primary_10_1128_MCB_00235_10 crossref_primary_10_1038_s41417_019_0123_9 crossref_primary_10_1186_1746_1596_7_8 crossref_primary_10_3390_epigenomes6030017 crossref_primary_10_1371_journal_pgen_1000155 crossref_primary_10_1093_nar_gkp882 crossref_primary_10_1111_acer_13976 crossref_primary_10_1016_j_oooo_2012_12_011 crossref_primary_10_1016_j_jtbi_2006_05_012 crossref_primary_10_1093_nar_gks197 crossref_primary_10_3892_ijo_2016_3743 crossref_primary_10_15252_embr_202154147 crossref_primary_10_1038_s41467_025_62114_0 crossref_primary_10_1074_jbc_M606203200 crossref_primary_10_1093_molehr_gal074 crossref_primary_10_3892_or_2022_8430 crossref_primary_10_1155_2008_565631 crossref_primary_10_1002_mrd_20968 crossref_primary_10_1016_j_devcel_2007_05_011 crossref_primary_10_1186_bcr2477 crossref_primary_10_1002_ijc_25365 crossref_primary_10_1101_gad_1536807 crossref_primary_10_1038_s41423_020_0505_9 crossref_primary_10_1128_MCB_00484_09 crossref_primary_10_1101_gr_114843_110 crossref_primary_10_7759_cureus_59503 crossref_primary_10_3390_cancers10090295 crossref_primary_10_1016_j_mad_2015_02_002 crossref_primary_10_1016_j_gene_2017_10_011 crossref_primary_10_1038_ncomms2058 crossref_primary_10_1242_dev_016402 crossref_primary_10_1371_journal_pone_0016702 crossref_primary_10_1016_j_etap_2021_103779 crossref_primary_10_1093_jn_137_12_2622 crossref_primary_10_1159_000502885 crossref_primary_10_1002_cbic_201000195 crossref_primary_10_14348_molcells_2015_2138 crossref_primary_10_1016_j_preme_2025_100023 crossref_primary_10_1186_1756_3305_6_167 crossref_primary_10_3390_plants12051047 crossref_primary_10_1007_s00253_022_12029_3 crossref_primary_10_1371_journal_pone_0061658 crossref_primary_10_1074_jbc_M112_443895 crossref_primary_10_1080_07357900802208590 crossref_primary_10_1186_s13059_015_0763_5 crossref_primary_10_1007_s00441_007_0537_9 crossref_primary_10_1016_j_biocel_2010_08_007 crossref_primary_10_1517_14728222_2010_525353 crossref_primary_10_3390_genes10010065 crossref_primary_10_1016_j_pharmthera_2014_09_005 crossref_primary_10_3390_ijms12128661 crossref_primary_10_1186_s12929_014_0073_3 crossref_primary_10_1038_s41467_020_17269_3 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1158/0008-5472.CAN-05-1980 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| ExternalDocumentID | 16423997 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIEHS NIH HHS grantid: ES 11858 |
| GroupedDBID | --- -ET .55 .GJ 18M 29B 2WC 34G 39C 3O- 53G 5GY 5RE 5VS 6J9 8WZ A6W ABOCM ACGFO ACIWK ACPRK ACSVP ADBBV ADCOW AENEX AFFNX AFHIN AFOSN AFRAH AFUMD AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW C1A CGR CS3 CUY CVF DIK DU5 EBS ECM EIF EJD F5P FRP GX1 H13 IH2 KQ8 L7B LSO MVM NPM OHT OK1 P0W P2P PQQKQ RCR RHF RHI RNS SJN TR2 UDS VH1 VXZ W2D W8F WH7 WHG WOQ X7M XJT YKV YZZ ZCG ZGI 7X8 AAFWJ AAJMC AETEA |
| ID | FETCH-LOGICAL-c436t-99fdb12c66a454cbde2b451ebb842e3de31cfe176877ef12677f46a68d6e6b1b2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 174 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000234915100015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0008-5472 |
| IngestDate | Wed Oct 01 13:18:14 EDT 2025 Wed Feb 19 01:42:52 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c436t-99fdb12c66a454cbde2b451ebb842e3de31cfe176877ef12677f46a68d6e6b1b2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 16423997 |
| PQID | 70684057 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_70684057 pubmed_primary_16423997 |
| PublicationCentury | 2000 |
| PublicationDate | 2006-01-15 |
| PublicationDateYYYYMMDD | 2006-01-15 |
| PublicationDate_xml | – month: 01 year: 2006 text: 2006-01-15 day: 15 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Cancer research (Chicago, Ill.) |
| PublicationTitleAlternate | Cancer Res |
| PublicationYear | 2006 |
| SSID | ssj0005105 |
| Score | 2.2996788 |
| Snippet | A major obstacle toward understanding how patterns of abnormal mammalian cytosine DNA methylation are established is the difficulty in quantitating the de novo... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 682 |
| SubjectTerms | Animals Colonic Neoplasms - genetics Colonic Neoplasms - pathology CpG Islands DNA (Cytosine-5-)-Methyltransferase 1 DNA (Cytosine-5-)-Methyltransferases - physiology DNA Methylation Drosophila - genetics Genetic Engineering Humans Tumor Cells, Cultured |
| Title | De novo CpG island methylation in human cancer cells |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/16423997 https://www.proquest.com/docview/70684057 |
| Volume | 66 |
| WOSCitedRecordID | wos000234915100015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV05T8MwFLYKRYiF-yinB1bT2vEVCQlVhcJAow6AukX1JXVJSlMq8e-xc8CEGFgyWEpsPb_Y73vXB8B1bIykkklk8ZQj6pxESsQMEYeV8hc8FSVN59uzSBI5mcTjFrhtamFCWmVzJpYHtcl18JF3RS-0JWHibv6OAmdUiK3WBBproB15QybotJj89ApndQJjCPAzP2ddv4OZ7H6P3Qz6SYgFe-jd-93GLO-a4c7_VrkLtmsbE_YrpdgDLZvtg81RHUU_APTewixf5XAwf4SzIuQ2wsAk_VnlxcFZBkvqPqiDSixgcO4Xh-B1-PAyeEI1ewLSNOJLFMfOKEw051PKqFbGEkUZtkpJSmxkbIS1s9jDDSGsw4QL4Sifcmm45QorcgTWszyzJwAybXr-W373nIfTOpbUMcuIR89Oa01MB1w10ki9doZVTTObfxRpI48OOK4Ems6rJhqph2mhrFac_vnuGdhq_B6YnYO28_-lvQAberWcFYvLctP9MxmPvgBBorS7 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=De+novo+CpG+island+methylation+in+human+cancer+cells&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Jair%2C+Kam-Wing&rft.au=Bachman%2C+Kurtis+E&rft.au=Suzuki%2C+Hiromu&rft.au=Ting%2C+Angela+H&rft.date=2006-01-15&rft.issn=0008-5472&rft.volume=66&rft.issue=2&rft.spage=682&rft_id=info:doi/10.1158%2F0008-5472.CAN-05-1980&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon |